Weight Loss Drugs

Weight-loss drug developers are shifting focus from total weight reduction to preserving muscle mass, as clinical trials from Novo Nordisk, Eli Lilly, and Regeneron target healthier body composition outcomes.

Three years ago, Novo Nordisk ruled the market with an iron hand, but Eli Lilly has made a massive overtake. The pill revolution, price drops in the USA, and a lawsuit — the drama behind a market worth hundreds of billions.